Contraception and Family Planning Practice Questions

Q: Which of the following is a true statement about the minipill?

Irregular vaginal bleeding may be a side effect.. The **Minipill**, or Progestogen-Only Pill (POP), is a contraceptive containing only a low dose of progestin without estrogen. ### **Explanation of Options** * **A. Irregular vaginal bleeding (Correct):** This is the most common side effect of POPs. Unlike combined pills, which provide a predictable withdrawal bleed due to the estrogen component stabilizing the endometrium, POPs often cause endometrial thinning and breakthrough spotting. Approximately 40% of users experience irregular bleeding, spotting, or amenorrhea. * **B. Combination with OCPs:** This is incorrect. The minipill is an alternative to Combined Oral Contraceptive Pills (COCPs), especially for women who have contraindications to estrogen (e.g., history of thromboembolism or hypertension). * **C. Use during lactation:** This is incorrect. The minipill is the **contraceptive of choice for lactating mothers**. Unlike estrogen, which suppresses milk production, progestins do not affect the quantity or quality of breast milk. * **D. Ectopic pregnancy:** This is incorrect. While the minipill reduces the absolute risk of pregnancy, if a woman *does* conceive while taking it, there is a **higher relative risk** that the pregnancy will be ectopic because progestins decrease fallopian tube motility. ### **High-Yield NEET-PG Pearls** * **Mechanism of Action:** Primarily works by **thickening cervical mucus** (preventing sperm penetration) and making the endometrium unfavorable for implantation. It does not consistently inhibit ovulation (ovulation occurs in ~60% of cycles). * **Strict Timing:** The minipill must be taken at the **same time every day**. A delay of more than **3 hours** is considered a "missed pill," requiring backup contraception for 48 hours. * **Ideal Candidate:** Lactating women, smokers over 35, and women with cardiovascular risks.

Q: A pregnant woman with an intrauterine contraceptive device (IUCD) in situ, where the IUCD tail is visible, what is the next recommended course of action?

Remove the IUCD. ### Explanation The management of a pregnancy with an intrauterine contraceptive device (IUCD) in situ depends primarily on the **visibility of the strings**. **Why Option B is Correct:** When a woman becomes pregnant with an IUCD and the strings are visible, the standard of care is **immediate removal of the IUCD**. Leaving the device in situ significantly increases the risk of: 1. **Septic Abortion:** A 20-fold increase in risk. 2. **Spontaneous Abortion (SAB):** The risk of SAB is approximately 50% if left in situ, which reduces to about 20–25% if the device is removed early. 3. **Preterm Labor and Chorioamnionitis:** Increased risk in the second and third trimesters. **Why Other Options are Incorrect:** * **Options A & C:** Continuing the pregnancy without intervention or just monitoring is dangerous due to the high risk of life-threatening pelvic sepsis and miscarriage. * **Option D:** Pregnancy termination is not medically mandated. If the woman desires to continue the pregnancy, the IUCD should be removed, and the pregnancy can proceed. The IUCD itself is **not teratogenic**. **High-Yield Clinical Pearls for NEET-PG:** * **Strings NOT visible:** Perform an ultrasound. If the IUCD is intra-decidual, **do not** attempt removal, as it may disrupt the gestational sac. * **Ectopic Risk:** While IUCDs are highly effective, if a pregnancy *does* occur, the **relative risk** of it being an ectopic pregnancy is higher (though the absolute risk is lower than in non-contraceptive users). * **Teratogenicity:** There is no evidence of increased congenital malformations in babies born with an IUCD in situ. * **Management Summary:** Strings visible $\rightarrow$ Pull/Remove; Strings not visible $\rightarrow$ Leave it alone and monitor.

Q: Which is the most likely complication of an intrauterine device (IUD)?

Hypofibrinogenemia. **Explanation:** The correct answer is **Hypofibrinogenemia**. While this may seem counterintuitive compared to common side effects like bleeding or pain, it is a recognized systemic complication associated with the chronic inflammatory response triggered by an IUD. **1. Why Hypofibrinogenemia is correct:** Intrauterine devices, particularly non-medicated ones, induce a local sterile inflammatory reaction in the endometrium. This leads to an increase in vascular permeability and the release of lysosomal enzymes and plasminogen activators. The chronic increase in **fibrinolytic activity** within the uterine cavity can lead to the systemic consumption of fibrinogen, resulting in hypofibrinogenemia. This is often the underlying mechanism for the increased menstrual blood loss (menorrhagia) seen in IUD users. **2. Why other options are incorrect:** * **Sterility:** IUDs do not cause permanent sterility. Fertility returns immediately upon removal. While Pelvic Inflammatory Disease (PID) can lead to tubal factor infertility, the IUD itself is not a cause of sterility. * **Cervical tear:** This is a rare mechanical complication that may occur during the *insertion* process (usually due to the tenaculum), but it is not a complication of the device itself. * **None of the above:** Incorrect, as hypofibrinogenemia is a documented hematological association. **High-Yield NEET-PG Pearls:** * **Most common side effect of IUD:** Bleeding (Menorrhagia). * **Most common cause for IUD removal:** Bleeding. * **Second most common cause for removal:** Pain. * **Mechanism of action (Cu-T):** Primarily spermicidal (due to sterile inflammatory response and Cu ions). * **Ideal time for insertion:** Within 10 days of the start of menstruation (to ensure the patient is not pregnant and the cervix is slightly dilated).

Q: What is the recommended lifespan of a Copper T 380A intrauterine device?

10 years. **Explanation:** The **Copper T 380A (CuT 380A)** is a highly effective, long-acting reversible contraceptive (LARC). The "380" refers to the surface area of copper wire (380 $mm^2$) wrapped around the vertical stem and the copper sleeves on the horizontal arms. This high copper content increases its efficacy and longevity. **Why Option D is Correct:** The FDA and the Government of India (under the National Family Planning Program) recommend a lifespan of **10 years** for the CuT 380A. The primary mechanism of action is the release of copper ions, which are spermicidal, inhibit sperm motility, and cause a sterile inflammatory response in the endometrium, preventing implantation. **Why Other Options are Incorrect:** * **Options A & C (3-4 years):** These are too short for modern copper IUDs. Older models like the Lippes Loop or CuT 200 had shorter durations, but they are no longer the standard of care. * **Option B (5 years):** This is the lifespan of the **CuT 375 (Multiload)** and the **Mirena (LNG-IUD)**. While Mirena is now often used for up to 8 years in some clinical guidelines, 5 years remains the standard duration for CuT 375. **High-Yield Clinical Pearls for NEET-PG:** * **Ideal Insertion Time:** Within 10 days of the onset of menstruation (to ensure the patient is not pregnant and the cervix is slightly dilated). * **Post-Placental Insertion:** Can be inserted within 48 hours of delivery (PPIUCD). * **Emergency Contraception:** CuT 380A is the **most effective** method of emergency contraception if inserted within 5 days (120 hours) of unprotected intercourse. * **Common Side Effects:** The most common side effect is **menorrhagia** (increased menstrual bleeding), followed by pelvic pain.

Q: A 27-year-old P2L2 presents to the OPD for contraceptive advice. She delivered a male child 3 weeks ago and is presently lactating. She has no contraindications to hormone use. What contraceptive method can be given?

Minipill (Progestin-only pill). **Explanation:** The primary concern in postpartum contraception for a lactating woman is the effect of hormones on the **quantity and quality of breast milk**, as well as the risk of **venous thromboembolism (VTE)**. **1. Why Option B (Minipill) is Correct:** Progestin-only pills (POPs) are the preferred hormonal method for breastfeeding women. According to the WHO Medical Eligibility Criteria (MEC), POPs can be started as early as **immediately postpartum** (Category 2 if 6 weeks). They do not suppress lactation or affect the nutritional quality of milk, making them safe for both the mother and the infant. **2. Why the other options are incorrect:** * **Option D (Combined OCPs):** These are **contraindicated** in the first 3–6 weeks postpartum. Estrogen suppresses prolactin, leading to decreased milk production. Furthermore, the postpartum period is a hypercoagulable state; estrogen increases the risk of VTE. (MEC Category 4 if <3 weeks; Category 3 if 3–6 weeks). * **Option A & C (DMPA and Implants):** While these are progestin-only methods, the WHO MEC traditionally suggests waiting until **6 weeks** postpartum for DMPA in breastfeeding women (Category 2) to avoid theoretical concerns regarding high-dose steroid exposure to the neonate during early development. The Minipill is considered a more immediate option at 3 weeks. **Clinical Pearls for NEET-PG:** * **Lactational Amenorrhea Method (LAM):** Effective only if the mother is exclusively breastfeeding, is amenorrheic, and the baby is <6 months old. * **IUCD (Cu-T):** Can be inserted within 48 hours (Postpartum IUCD) or after 6 weeks (Interval IUCD). It should *not* be inserted between 48 hours and 6 weeks due to high perforation/expulsion risks. * **Ideal Postpartum Sterilization:** Usually performed within 24–48 hours or after 6 weeks.

Q: Which of the following statements is TRUE regarding spermicides found in vaginal foams, creams, and suppositories?

The active agent in these spermicides is nonoxynol-9.. **Explanation:** **1. Why Option A is Correct:** The primary active ingredient in most commercially available spermicides (foams, creams, gels, and suppositories) is **Nonoxynol-9**. It is a non-ionic surfactant that works by disrupting the sperm cell membrane (lipids), leading to loss of motility and eventual cell death. This prevents the sperm from reaching and fertilizing the ovum. **2. Why the Other Options are Incorrect:** * **Option B:** **Levonorgestrel** is a synthetic progestogen used in hormonal contraceptives (like the LNG-IUS, POPs, or emergency contraceptive pills), not in chemical spermicides. * **Option C:** Effectiveness is generally **lower in younger users**. This is because younger populations are typically more fertile and have a higher coital frequency, leading to a higher failure rate compared to older users. * **Option D:** Spermicides used alone have a high failure rate (approximately 18–28% with typical use). Their effectiveness is **lower than the diaphragm** and other barrier methods. For optimal efficacy, spermicides are recommended to be used in conjunction with a diaphragm or condom. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Nonoxynol-9 acts as a detergent that destroys the sperm's plasma membrane. * **HIV Risk:** Frequent use of Nonoxynol-9 can cause vaginal and cervical irritation/epithelial disruption, which may actually **increase the risk of HIV transmission** and other STIs. * **Application:** Spermicides must be applied high in the vagina near the cervix, usually 10–30 minutes before intercourse, and their effect lasts for about one hour. * **Pearl:** Spermicides do not protect against STIs; in fact, the WHO does not recommend Nonoxynol-9 for women at high risk of HIV.

Q: What is the primary mechanism of action of oral contraceptives containing ethinyl estradiol and a progestin?

Inhibition of ovulation. Combined Oral Contraceptive Pills (COCPs) containing both ethinyl estradiol and a progestin act via multiple mechanisms, but their **primary** mechanism of action is the **inhibition of ovulation**. ### Why Option A is Correct The combination of hormones exerts negative feedback on the hypothalamic-pituitary-ovarian axis: * **Estrogen** suppresses the release of **FSH** (Follicle Stimulating Hormone), which prevents the recruitment and maturation of a dominant follicle. * **Progestin** suppresses the release of **LH** (Luteinizing Hormone), thereby preventing the LH surge required for ovulation. Without follicle maturation or an LH surge, ovulation cannot occur. ### Why Other Options are Incorrect * **Option B (Inhibition of implantation):** While COCPs cause endometrial atrophy (making it less receptive), this is a secondary/backup effect, not the primary mechanism. * **Option C (Thickening of cervical mucus):** This is the **primary** mechanism for **Progestogen-Only Pills (POPs)** and the Minipill. In COCPs, this is a secondary mechanism that prevents sperm penetration. ### High-Yield NEET-PG Pearls * **Most potent component for ovulation inhibition:** Progestin (it is responsible for the mid-cycle LH suppression). * **Pearl on Failure Rate:** The "Perfect Use" failure rate of COCPs is **0.3%**, while "Typical Use" is approximately **9%**. * **Non-contraceptive benefits:** COCPs reduce the risk of **Ovarian and Endometrial cancers** (protective effect). * **Contraindication:** Avoid in women >35 years who smoke (increased risk of venous thromboembolism).

Question 1

Which of the following is a true statement about the minipill?

Accepted Answer

Irregular vaginal bleeding may be a side effect.

Answer

It is used in combination with oral contraceptive pills.

Answer

It cannot be used during lactation.

Answer

It prevents ectopic pregnancy.

Question 2

A pregnant woman with an intrauterine contraceptive device (IUCD) in situ, where the IUCD tail is visible, what is the next recommended course of action?

Accepted Answer

Remove the IUCD

Answer

Continue the pregnancy without intervention

Answer

Continue the pregnancy with watchful monitoring

Answer

Remove the IUCD and terminate the pregnancy

Question 3

Which is the most likely complication of an intrauterine device (IUD)?

Accepted Answer

Hypofibrinogenemia

Answer

Sterility

Answer

Cervical tear

Answer

None of the above

Question 4

What is the contraceptive method of choice in lactating mothers?

Accepted Answer

Progesterone-only pills

Answer

Barrier method

Answer

Combined oral contraceptive pills

Answer

Lactational amenorrhea

Question 5

What is the best method of contraception for a commercial sex worker?

Accepted Answer

Barrier methods

Answer

Intrauterine contraceptive device (IUCD)

Answer

Oral contraceptive pills (OCP)

Answer

Permanent sterilization

Question 6

Peritoneum is opened in all of the following sterilization procedures except?

Accepted Answer

Vasectomy

Answer

Mini lap

Answer

Laparoscopy

Answer

Transvaginal tubectomy

Question 7

What is the recommended lifespan of a Copper T 380A intrauterine device?

Accepted Answer

10 years

Answer

4 years

Answer

5 years

Answer

3 years

Question 8

A 27-year-old P2L2 presents to the OPD for contraceptive advice. She delivered a male child 3 weeks ago and is presently lactating. She has no contraindications to hormone use. What contraceptive method can be given?

Accepted Answer

Minipill (Progestin-only pill)

Answer

DMPA (Depot medroxyprogesterone acetate)

Answer

Levonorgestrel implants

Answer

Combined oral contraceptive pills (OCPs)

Question 9

Which of the following statements is TRUE regarding spermicides found in vaginal foams, creams, and suppositories?

Accepted Answer

The active agent in these spermicides is nonoxynol-9.

Answer

The active agent in these spermicides is levonorgestrel.

Answer

Effectiveness is higher in younger users.

Answer

Effectiveness is higher than that of the diaphragm.

Question 10

What is the primary mechanism of action of oral contraceptives containing ethinyl estradiol and a progestin?

Accepted Answer

Inhibition of ovulation

Answer

Inhibition of implantation

Answer

Thickening of cervical mucus

Answer

None of the above

Contraception and Family Planning — MCQs

Contraception and Family Planning — MCQs

On this page

Practice by Chapter

Want unlimited practice?